abrdn Blue Chip International Portfolio, Series 6 abrdn Medical Science Innovation Portfolio, Series 8 Blue Chip Dividend Portfolio, Series 16 Blue Chip Growth Portfolio, Series 42 US Capital Strength Portfolio, Series 28 REFERENCE TRUST AGREEMENTReference Trust Agreement • May 20th, 2024 • Guggenheim Defined Portfolios, Series 2404
Contract Type FiledMay 20th, 2024 CompanyThis Reference Trust Agreement dated as of May 20, 2024, between Guggenheim Funds Distributors, LLC, as Depositor, and The Bank of New York Mellon, as Trustee, sets forth certain provisions in full and incorporates other provisions by reference to the document entitled “Standard Terms and Conditions of Trust For Series Formed on or Subsequent to December 18, 2001” (herein called the “Standard Terms and Conditions of Trust”), and such provisions as are set forth in full and such provisions as are incorporated by reference constitute a single instrument. All references herein to Articles and Sections are to Articles and Sections of the Standard Terms and Conditions of Trust.
Portfolio Support and License AgreementPortfolio Support and License Agreement • May 20th, 2024 • Guggenheim Defined Portfolios, Series 2404 • Illinois
Contract Type FiledMay 20th, 2024 Company JurisdictionThis Portfolio Support and License Agreement (the “Agreement”), dated as of May 20, 2024, is made by and between abrdn Inc., a Delaware corporation (“Consultant/Licensor”), and Guggenheim Funds Distributor, LLC., (“GFD” or “Licensee”) as sponsor to, abrdn Blue Chip International Portfolio, Series 6 (the “Trust”).